ImmunityBio, Inc. Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ImmunityBio, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
  • ImmunityBio, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.38M, a 25% decline year-over-year.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2024 was $10.6M, a 11.6% increase from 2023.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2023 was $9.54M, a 6.87% decline from 2022.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2022 was $10.2M, a 13.4% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10.6M +$1.1M +11.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 $9.54M -$703K -6.87% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $10.2M +$1.21M +13.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $9.03M +$1.19M +15.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $7.84M +$272K +3.59% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $7.57M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.